Imaging technologies in urology have become integral tools for diagnosing and treating various urinary and reproductive system conditions. These technologies range from ultrasounds and CT scans to ...
MDxHealth SA, a maker of noninvasive urology tests used to diagnose prostate cancer that’s struggled to gain traction as a public company (Nasdaq: MDXH), looks closer to turning an important corner.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback